Article
Circulating matrix γ-carboxyglutamate protein (MGP) species are refractory to vitamin K treatment in a new case of Keutel syndrome.
Journal of thrombosis and haemostasis : JTH - 1 Jun 2011
Cranenburg E C M, VAN Spaendonck-Zwarts K Y, Bonafe L, Mittaz Crettol L, Rödiger L A, Dikkers F G, VAN Essen A J, Superti-Furga A, Alexandrakis E, Vermeer C, Schurgers L J, Laverman G D
Abstract excerpt
BACKGROUND AND OBJECTIVES: Matrix γ-carboxyglutamate protein (MGP), a vitamin K-dependent protein, is recognized as a potent local inhibitor of vascular calcification. Studying patients with Keutel syndrome (KS), a rare autosomal recessive disorder resulting from MGP mutations, provides an opport...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
